Literature DB >> 26633783

Varicella-Zoster Virus Infections.

Don Gilden.   

Abstract

PURPOSE OF REVIEW: This article describes the clinical features and laboratory and imaging abnormalities of the protean neurologic disorders produced by varicella-zoster virus (VZV) reactivation. Diseases include not only zoster, but also chronic pain (postherpetic neuralgia), meningoencephalitis and cerebellitis, single or multiple cranial nerve palsies (polyneuritis cranialis), myelopathy (myelitis and spinal cord infarction), and VZV vasculopathy of intracerebral and extracerebral arteries that causes ischemic or hemorrhagic stroke, aneurysm, subarachnoid and intracerebral hemorrhage, arterial ectasia, and dissection. The article addresses accurate diagnosis of VZV infection of the nervous system in the absence of rash, and optimal treatment. RECENT
FINDINGS: All neurologic disorders produced by VZV can occur in the absence of rash. Diagnosis is confirmed by the presence of VZV DNA or anti-VZV antibodies in CSF. Based on evidence from recent studies, VZV has been implicated as a cause of giant cell arteritis.
SUMMARY: Clinicians must be aware that VZV reactivation produces multiple disorders of the central nervous system (CNS) and peripheral nervous system, often without rash. Rapid virologic verification and prompt treatment with antiviral agents can lead to complete recovery, even in patients with protracted disease.

Entities:  

Mesh:

Year:  2015        PMID: 26633783     DOI: 10.1212/CON.0000000000000246

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  7 in total

1.  An Atypical Presentation of Varicella Zoster (VZV) Vasculopathy.

Authors:  Zafer Keser; Gerson Suarez-Cedeno; Ram K Saha; Quynh Huong V Pham; Amanda L Jagolino; Tzu-Ching Wu
Journal:  J Vasc Interv Neurol       Date:  2018-06

2.  Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion.

Authors:  Randall J Cohrs; Katherine S Lee; Addilynn Beach; Bridget Sanford; Nicholas L Baird; Christina Como; Chiharu Graybill; Dallas Jones; Eden Tekeste; Mitchell Ballard; Xiaomi Chen; David Yalacki; Seth Frietze; Kenneth Jones; Tihana Lenac Rovis; Stipan Jonjić; Jürgen Haas; Don Gilden
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

3.  Recovery of intracranial stenoses in varicella zoster virus vasculitis after long-term treatment with valacyclovir and prednisolone.

Authors:  Markus Kraemer; Daniel Strunk; Jana Becker; Roland Veltkamp; Peter Berlit
Journal:  Neurol Res Pract       Date:  2022-05-16

4.  Induction of varicella zoster virus DNA replication in dissociated human trigeminal ganglia.

Authors:  Randall J Cohrs; Hussain Badani; Nicholas L Baird; Teresa M White; Bridget Sanford; Don Gilden
Journal:  J Neurovirol       Date:  2016-09-28       Impact factor: 2.643

Review 5.  Cerebrovascular events after herpes zoster infection: a risk that should be not underestimated.

Authors:  Marco Zuin; Gianluca Rigatelli; Alessandro Adami
Journal:  J Neurovirol       Date:  2019-05-08       Impact factor: 3.739

6.  Pharyngeal dysphagia due to Varicella zoster virus meningoradiculitis and full recovery: Case report and endoscopic findings.

Authors:  Paul Muhle; Sonja Suntrup-Krueger; Rainer Dziewas; Tobias Warnecke
Journal:  SAGE Open Med Case Rep       Date:  2018-02-11

7.  A Rare Presentation of Cranial Polyneuropathy Without Rash Caused by Varicella Zoster Virus.

Authors:  Mehmet Tecellioglu; Suat Kamisli; Mehmet Fatih Erbay; Ozden Kamisli; Cemal Ozcan
Journal:  Med Arch       Date:  2017-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.